Medical Xpress August 15, 2024
Robin Foster

The Biden administration said Thursday that it has signed deals with drug companies that will lower the prices on 10 of the most popular and expensive drugs used by American seniors.

Taxpayers should save $6 billion because of the new , while seniors using Medicare could save roughly $1.5 billion on their medications, the U.S. Centers for Medicare and Medicaid Services said in a news release announcing the new prices.

Those negotiated prices should lower the cost of drugs used by millions of older Americans to help manage diabetes, blood cancers and to prevent heart failure or .

The medications affected include the blood thinners Xarelto and Eliquis and the diabetes drugs Jardiance and Januvia. Medicare spent $50 billion...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Congress / White House, Govt Agencies, HHS, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech
Podcast: Medicare Shared Savings Program Mints $2B Win for Value-Based Care w/ Frank McStay
Dr. Oz, RFK Jr. on Medicare, Medicaid: 10 notes
How State Health Insurance Assistance Programs Can Support Medicare Beneficiaries With Limited English Proficiency
How Affordable Is Health Care for Medicare Beneficiaries?
New HHS leader could overhaul Medicare physician reimbursement: reports

Share This Article